= Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of The Securities Exchange Act of 1934, as amended. Unoprostone Exclusive Manufacturing and...Exclusive Manufacturing and Supply Agreement • May 11th, 2009 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2009 Company Industry JurisdictionTHIS UNOPROSTONE EXCLUSIVE MANUFACTURING AND SUPPY AGREEMENT (“Agreement”) is made this 23 day of April, 2009 (the “Effective Date”), by and among Sucampo Pharma Americas, Inc., (“SPA”) a corporation organized and existing under the laws of the State of Delaware, U.S.A., (and a wholly-owned subsidiary of Sucampo Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware, U.S.A.), and having its principal office at 4520 East West Highway, Third Floor, Bethesda, Maryland 20814, and R Tech Ueno, Ltd., (“RTU”) a corporation organized and existing under the laws of Japan and having its registered office at Uchisaiwai-cho 1-1-7, Chiyoda-ku, Tokyo, Japan, 100-0011 (each referred to herein as a “Party” and collectively as the “Parties”).
= Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of The Securities Exchange Act of 1934, as amended. Unoprostone NDA Transfer, Patent and...Nda Transfer, Patent and Know-How Licensing, and Data Sharing Agreement • May 11th, 2009 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2009 Company Industry JurisdictionTHIS UNOPROSTONE NDA TRANSFER, PATENT AND KNOW-HOW LICENSING AND DATA SHARING AGREEMENT (“Agreement”) is made this 23 day of April, 2009 (the “Effective Date”), by and among Sucampo Pharma Americas, Inc. (“SPA”), a corporation organized and existing under the laws of the State of Delaware, U.S.A., ( a wholly-owned subsidiary of Sucampo Pharmaceuticals, Inc., (“SPI”) a corporation organized and existing under the laws of the state of Delaware, U.S.A.), and having its principal office at 4520 East West Highway, Third Floor, Bethesda, Maryland 20814, and R Tech Ueno, Ltd. (“RTU”), a corporation organized and existing under the laws of Japan and having its registered office at 1-1-7 Uchisaiwai-cho, Chiyoda-ku, Tokyo, Japan ,100-0011 (SPA and RTU each referred to herein as a “Party” and collectively as the “Parties”).